These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38231148)

  • 1. Anticoagulation for Atrial Fibrillation in Advanced CKD: Can Observational Studies Provide the Answer?
    Weiner DE; Sarnak MJ
    Am J Kidney Dis; 2024 Mar; 83(3):288-290. PubMed ID: 38231148
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel oral anticoagulants in patients with chronic kidney disease and atrial fibrillation.
    Stamellou E; Floege J
    Nephrol Dial Transplant; 2018 Oct; 33(10):1683-1689. PubMed ID: 29206932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulants in atrial fibrillation patients with chronic kidney disease.
    Hart RG; Eikelboom JW; Ingram AJ; Herzog CA
    Nat Rev Nephrol; 2012 Oct; 8(10):569-78. PubMed ID: 22825670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stroke prevention in atrial fibrillation patients with chronic kidney disease.
    Hart RG; Eikelboom JW; Brimble KS; McMurtry MS; Ingram AJ
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S71-8. PubMed ID: 23790601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation.
    Di Lullo L; Ronco C; Cozzolino M; Russo D; Russo L; Di Iorio B; De Pascalis A; Barbera V; Galliani M; Vitaliano E; Campana C; Santoboni F; Bellasi A
    Thromb Res; 2017 Jul; 155():38-47. PubMed ID: 28482261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral Anticoagulation Use in Individuals With Atrial Fibrillation and Chronic Kidney Disease: A Review.
    Wing SL; Mavrakanas TA; Harel Z
    Semin Nephrol; 2024 Mar; 44(2):151517. PubMed ID: 38744617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial fibrillation in CKD: balancing the risks and benefits of anticoagulation.
    Ng KP; Edwards NC; Lip GY; Townend JN; Ferro CJ
    Am J Kidney Dis; 2013 Sep; 62(3):615-32. PubMed ID: 23746378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oral anticoagulation in chronic kidney disease with atrial fibrillation].
    Expósito V; Seras M; Fernández-Fresnedo G
    Med Clin (Barc); 2015 May; 144(10):452-6. PubMed ID: 24889748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of anticoagulation, ischemic stroke, and hemorrhage in elderly adults with chronic kidney disease and atrial fibrillation.
    Keskar V; McArthur E; Wald R; Harel Z; Zimmerman D; Molnar AO; Garg AX; Lam NN; McCallum MK; Bota SE; Perl J; Sood MM
    Kidney Int; 2017 Apr; 91(4):928-936. PubMed ID: 28017326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demystifying the Benefits and Harms of Anticoagulation for Atrial Fibrillation in Chronic Kidney Disease.
    Garlo KG; Steele DJR; Nigwekar SU; Chan KE
    Clin J Am Soc Nephrol; 2019 Jan; 14(1):125-136. PubMed ID: 30593489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Stroke, Bleeding, and Death in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease.
    Arnson Y; Hoshen M; Berliner-Sendrey A; Reges O; Balicer R; Leibowitz M; Avgil Tsadok M; Haim M
    Cardiology; 2020; 145(3):178-186. PubMed ID: 31955174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation in Patients with Chronic Kidney Disease.
    Elenjickal EJ; Travlos CK; Marques P; Mavrakanas TA
    Am J Nephrol; 2024; 55(2):146-164. PubMed ID: 38035566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which anticoagulants should be used for stroke prevention in non-valvular atrial fibrillation and severe chronic kidney disease?
    Kalra PA; Burlacu A; Ferro CJ; Covic A
    Curr Opin Nephrol Hypertens; 2018 Nov; 27(6):420-425. PubMed ID: 30020140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Anticoagulation in Patients With Advanced Chronic Kidney Disease and Atrial Fibrillation: Beyond Anticoagulation.
    Dhaese SAM; De Vriese AS
    Mayo Clin Proc; 2023 May; 98(5):750-770. PubMed ID: 37028979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation in atrial fibrillation and co-existent chronic kidney disease: efficacy versus safety.
    Salim I; Al Suwaidi J; Ghadban W; Salam AM
    Expert Opin Drug Saf; 2013 Jan; 12(1):53-63. PubMed ID: 23095103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel anticoagulants for stroke prevention in atrial fibrillation and chronic kidney disease.
    Turagam MK; Addepally NS; Velagapudi P
    Expert Rev Cardiovasc Ther; 2013 Oct; 11(10):1297-9. PubMed ID: 24138517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non vitamin-K dependent oral anticoagulants (NOACs) in chronic kidney disease patients with non-valvular atrial fibrillation].
    Di Lullo L; Barbera V; Bellasi A; Cozzolino M; Russo D; Otranto G; Santoboni F; Ronco C
    G Ital Nefrol; 2017 Apr; 34(2):58-73. PubMed ID: 28682563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT-AF.
    Washam JB; Holmes DN; Thomas LE; Pokorney SD; Hylek EM; Fonarow GC; Mahaffey KW; Gersh BJ; Kowey PR; Ansell JE; Go AS; Reiffel JA; Freeman JV; Singer DE; Naccarelli G; Blanco R; Peterson ED; Piccini JP
    J Am Heart Assoc; 2018 Sep; 7(18):e008928. PubMed ID: 30371218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial Fibrillation in Patients with Chronic Kidney Disease.
    Kotalczyk A; Ding WY; Wong CF; Rao A; Gupta D; Lip GYH
    Cardiol Clin; 2021 Aug; 39(3):435-446. PubMed ID: 34247756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New oral anticoagulants in patients with chronic kidney disease.
    Belmar Vega L; de Francisco ALM; Bada da Silva J; Galván Espinoza L; Fernández Fresnedo G
    Nefrologia; 2017; 37(3):244-252. PubMed ID: 27939514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.